ARPO Aerpio Pharmaceuticals Inc

DGAP-News: Geon Network Alpha App Reaches Major Milestone

DGAP-News: Geon Network Limited / Key word(s): Miscellaneous
Geon Network Alpha App Reaches Major Milestone

11.12.2018 / 16:45
The issuer is solely responsible for the content of this announcement.


Gibraltar--(Newsfile Corp. - December 11, 2018) - Geon Network Limited ('GEON', 'Geon Network' or 'Company') today announced that the release of its Geon Network App ('GeonApp') available at the Apple Store and Google Play has reached its first major milestone with over 10,000 user downloads. The initial alpha GeonApp was launched for Android OS on October 25, 2018 and for iOS on October 27, 2019.

These are exciting times for the Geon Network.

In early October 2018, Geon Network filed a US Patent Application #: 62/743,365 for GEOMINING - DISTRIBUTING DIGITAL ASSETS USING GEOLOCATED BEACONS.

Since the launch of the GeonApp in late October, Geon Network's global community has been and continues to grow rapidly with strong supporters emerging in multiple countries, boosting local adoption. To date, over 5,000 GEONs have been created all around the world and the total number of GeonApp downloads recently surpassed 10,000.

According to , this places the GeonApp in the top 13% of the most popular (by number of downloads) apps available for Android OS if compared to the statistics available for Q1 of 2018.

'We are overwhelmed by the response. It's great to see that people all around the world understand our vision and most importantly - enjoy participating in it.' - Robert Radek, CEO.

During the coming weeks, the Company plans to introduce many new features, bringing real-world value to the Geon Network further boosting adoption. The release of the GEON token to the public and its implementation within the GeonApp is expected in late Q1 2019, however, other business and user engagement initiatives will be implemented as early as the second half of December 2018.

Geon Network is about to run its GEONs for the Holidays promotion, wherein 100 secret message GEON beacons will be planted all over the world. Each will contain a cryptocurrency wallet address with funds available to collect by the local community.

The promotion will highlight one of many ways that the GeonApp can be used in various marketing and charity scenarios, while engaging its user base.

More details about the promotion will be released in the coming days via official company social media channels as listed below.

Geon Network is also busy with finalising deals with highly respected business partners around the world. This will result in various companies using the GeonApp to boost their own marketing strategies. Discount codes and other forms of digital goods distribution is planned to begin before the end of the year.

More information on Geon Network's upcoming partnerships and features will be released shortly.

The Company has recently received public accolades for the launch of GEON. Please visit for more information.

Geon Network Limited is continuing to review financing offers and interested parties should contact Mr. Robert Radek, CEO.

About Geon Network Limited -

Geon Network Limited, a Gibraltar Corporation is the owner and operator of the Geon Network.

The Geon Network is a platform that delivers a brand new class of applications based on geolocation. Secured by blockchain technology and enhanced by augmented reality, Geon Network represents an entirely new way to distribute value.

What makes Geon Network stand out is that the recipient does not have to have an address stored on the blockchain in order to receive funds. Instead, they simply provide a proof-of-location to validate the transaction on the network. All of that is done via the Geon Network app running on IOS/Android.

The Geon Network App is a tool which helps you securely transfer, exchange and store value, regardless of the local infrastructure - using only a smartphone. The transfer of value is done via GEONs - virtual beacons planted in specific locations via the Geon App. GEON beacons hold GEON Coins, which can be acquired either by converting fiat or cryptocurrency, or through geomining, a brand new mining concept based on proof-of-location, introduced by the Geon Network.

For more information please contact:

Robert Radek
Chief Executive Officer
Geon Network Limited

Medium blog:
Linkedin:
Facebook:
Twitter:
Telegram:
GitHub:
Instagram:
YouTube:

newsinfo.php?i=41570&f=196

Click on, or paste the following link into your web browser, to view the associated documents /release/41570


11.12.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Geon Network Limited
Gibraltar

 
End of News DGAP News Service

756849  11.12.2018 

fncls.ssp?fn=show_t_gif&application_id=756849&application_name=news&site_id=research_pool
EN
11/12/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aerpio Pharmaceuticals Inc

 PRESS RELEASE

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced it will join both the U.S. small cap Russell 2000® Index and broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective immediately after the U.S. market opens on June 24, 2022 according to a preliminary list of add...

 PRESS RELEASE

Aadi Bioscience to Present at the Jefferies Global Healthcare Conferen...

Aadi Bioscience to Present at the Jefferies Global Healthcare Conference LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced members of the Aadi senior management team will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY June 8-10, 2022. Founder, Chief Executive Officer and President, Neil Desai, Ph.D. is scheduled to present live during a fire...

 PRESS RELEASE

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor R...

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced the appointment of Marcy Graham to the new position of Senior Vice President, Investor Relations (IR) and Corporate Communications. “We are delighted to welcome Marcy to the team, as she brings extensive experience to ...

 PRESS RELEASE

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in ...

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting Target tumor reductions observed in advanced malignant PEComa patients harboring TSC1 or TSC2 inactivating alterations regardless of prior mTOR inhibitor exposure LOS ANGELES, May 26, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced presentat...

 PRESS RELEASE

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Co...

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi’s executive team will participate virtually in the H.C. Wainwright Global Investment Conference, to be held in person and virtually May 23-26, 2022 in Mia...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch